Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	protein-glutamine gamma-glutamyltransferase activity	TGM2 F13A1	3.59e-04	9	64	2	GO:0003810
GeneOntologyMolecularFunction	histone binding	BPTF L3MBTL1 CHD5 NAP1L1 BAZ1B	1.60e-03	265	64	5	GO:0042393
GeneOntologyMolecularFunction	3',5'-cyclic-AMP phosphodiesterase activity	PDE6A PDE9A	2.24e-03	22	64	2	GO:0004115
GeneOntologyMolecularFunction	methylated histone binding	BPTF L3MBTL1 CHD5	2.66e-03	86	64	3	GO:0035064
GeneOntologyMolecularFunction	3',5'-cyclic-GMP phosphodiesterase activity	PDE6A PDE9A	2.67e-03	24	64	2	GO:0047555
GeneOntologyMolecularFunction	methylation-dependent protein binding	BPTF L3MBTL1 CHD5	2.84e-03	88	64	3	GO:0140034
GeneOntologyMolecularFunction	3',5'-cyclic-nucleotide phosphodiesterase activity	PDE6A PDE9A	2.89e-03	25	64	2	GO:0004114
GeneOntologyMolecularFunction	cyclic-nucleotide phosphodiesterase activity	PDE6A PDE9A	3.37e-03	27	64	2	GO:0004112
GeneOntologyMolecularFunction	ATP-dependent activity	ACSL6 BPTF UBA7 KIF26B CHD5 CHD9 HSP90AA2P	3.42e-03	614	64	7	GO:0140657
Domain	DDT	BPTF BAZ1B	1.15e-04	5	64	2	SM00571
Domain	WSD	BPTF BAZ1B	1.15e-04	5	64	2	PF15613
Domain	WHIM1	BPTF BAZ1B	1.15e-04	5	64	2	PF15612
Domain	DDT_dom	BPTF BAZ1B	1.15e-04	5	64	2	IPR018501
Domain	WHIM1_dom	BPTF BAZ1B	1.15e-04	5	64	2	IPR028942
Domain	WHIM2_dom	BPTF BAZ1B	1.15e-04	5	64	2	IPR028941
Domain	DDT	BPTF BAZ1B	1.72e-04	6	64	2	PS50827
Domain	Transglut_N	TGM2 F13A1	4.10e-04	9	64	2	PF00868
Domain	TRANSGLUTAMINASES	TGM2 F13A1	4.10e-04	9	64	2	PS00547
Domain	Transglutaminase_N	TGM2 F13A1	4.10e-04	9	64	2	IPR001102
Domain	Transglut_C	TGM2 F13A1	4.10e-04	9	64	2	PF00927
Domain	-	TGM2 F13A1	4.10e-04	9	64	2	3.90.260.10
Domain	Gln_gamma-glutamylTfrase_euk	TGM2 F13A1	4.10e-04	9	64	2	IPR023608
Domain	Transglutaminase_AS	TGM2 F13A1	4.10e-04	9	64	2	IPR013808
Domain	Transglutaminase_C	TGM2 F13A1	5.11e-04	10	64	2	IPR008958
Domain	TGc	TGM2 F13A1	6.23e-04	11	64	2	SM00460
Domain	Transglut_core	TGM2 F13A1	6.23e-04	11	64	2	PF01841
Domain	Transglutaminase-like	TGM2 F13A1	6.23e-04	11	64	2	IPR002931
Domain	Zinc_finger_PHD-type_CS	BPTF CHD5 BAZ1B	1.44e-03	65	64	3	IPR019786
Domain	PDEase	PDE6A PDE9A	1.90e-03	19	64	2	IPR023088
Domain	PHD	BPTF CHD5 BAZ1B	2.17e-03	75	64	3	PF00628
Domain	PDEase_I	PDE6A PDE9A	2.33e-03	21	64	2	PF00233
Domain	PDEASE_I	PDE6A PDE9A	2.33e-03	21	64	2	PS00126
Domain	PDEase_CS	PDE6A PDE9A	2.33e-03	21	64	2	IPR023174
Domain	Znf_PHD-finger	BPTF CHD5 BAZ1B	2.52e-03	79	64	3	IPR019787
Domain	-	PDE6A PDE9A	2.55e-03	22	64	2	1.10.1300.10
Domain	PDEase_catalytic_dom	PDE6A PDE9A	2.79e-03	23	64	2	IPR002073
Domain	HDc	PDE6A PDE9A	3.04e-03	24	64	2	SM00471
Domain	HD/PDEase_dom	PDE6A PDE9A	3.04e-03	24	64	2	IPR003607
Domain	Chromo_domain	CHD5 CHD9	3.04e-03	24	64	2	IPR023780
Domain	PHD	BPTF CHD5 BAZ1B	3.53e-03	89	64	3	SM00249
Domain	Bromodomain_CS	BPTF BAZ1B	3.56e-03	26	64	2	IPR018359
Domain	Chromo	CHD5 CHD9	3.56e-03	26	64	2	PF00385
Domain	Znf_PHD	BPTF CHD5 BAZ1B	3.76e-03	91	64	3	IPR001965
Domain	CHROMO_1	CHD5 CHD9	4.13e-03	28	64	2	PS00598
Domain	CHROMO_2	CHD5 CHD9	4.13e-03	28	64	2	PS50013
Domain	ZF_PHD_2	BPTF CHD5 BAZ1B	4.24e-03	95	64	3	PS50016
Domain	ZF_PHD_1	BPTF CHD5 BAZ1B	4.37e-03	96	64	3	PS01359
Domain	SNF2_N	CHD5 CHD9	5.37e-03	32	64	2	IPR000330
Domain	Chromodomain-like	CHD5 CHD9	5.37e-03	32	64	2	IPR016197
Domain	SNF2_N	CHD5 CHD9	5.37e-03	32	64	2	PF00176
Domain	Chromo/shadow_dom	CHD5 CHD9	5.70e-03	33	64	2	IPR000953
Domain	CHROMO	CHD5 CHD9	5.70e-03	33	64	2	SM00298
Domain	MAGE	MAGEA10 NSMCE3	6.04e-03	34	64	2	SM01373
Domain	MAGE	MAGEA10 NSMCE3	6.76e-03	36	64	2	PS50838
Domain	MAGE	MAGEA10 NSMCE3	6.76e-03	36	64	2	PF01454
Domain	MHD_dom	MAGEA10 NSMCE3	6.76e-03	36	64	2	IPR002190
Pubmed	Differential effects of Tat proteins derived from HIV-1 subtypes B and recombinant CRF02_AG on human brain microvascular endothelial cells: implications for blood-brain barrier dysfunction.	PCSK5 TGM2 TNFSF10 C7 LY75 F13A1	4.68e-08	105	65	6	24667918
Pubmed	Spatial transcriptomics identifies spatially dysregulated expression of GRM3 and USP47 in amyotrophic lateral sclerosis.	GRM3 USP47	3.44e-06	2	65	2	31925813
Pubmed	KCNK5 Regulating Potassium Efflux and Inducing Pyroptosis in Corneal Epithelial Cells Through TNFSF10-Mediated Autophagy in Dry Eye.	TNFSF10 KCNK5	3.44e-06	2	65	2	38236186
Pubmed	Factor XIIIA mobilizes transglutaminase 2 to induce chondrocyte hypertrophic differentiation.	TGM2 F13A1	3.44e-06	2	65	2	18544639
Pubmed	Role of transglutaminases in cuff-induced atherosclerotic lesion formation in femoral arteries of ApoE3 Leiden mice.	TGM2 F13A1	3.44e-06	2	65	2	20810110
Pubmed	Reactivity of the N-terminal region of fibronectin protein to transglutaminase 2 and factor XIIIA.	TGM2 F13A1	3.44e-06	2	65	2	21757696
Pubmed	Impaired clot retraction in factor XIII A subunit-deficient mice.	TGM2 F13A1	3.44e-06	2	65	2	19996413
Pubmed	Transglutaminase activity regulates osteoblast differentiation and matrix mineralization in MC3T3-E1 osteoblast cultures.	TGM2 F13A1	3.44e-06	2	65	2	16469487
Pubmed	Expression and localization of plasma transglutaminase factor XIIIA in bone.	TGM2 F13A1	3.44e-06	2	65	2	17341477
Pubmed	Transglutaminases in mineralized tissues.	TGM2 F13A1	3.44e-06	2	65	2	16368540
Pubmed	Cystatin D (CST5): An ultra-early inflammatory biomarker of traumatic brain injury.	TNFSF10 AXIN1	1.03e-05	3	65	2	28694499
Pubmed	Transglutaminases factor XIII-A and TG2 regulate resorption, adipogenesis and plasma fibronectin homeostasis in bone and bone marrow.	TGM2 F13A1	1.03e-05	3	65	2	28387755
Pubmed	Transglutaminase 2 and Factor XIII catalyze distinct substrates in differentiating osteoblastic cell line: utility of highly reactive substrate peptides.	TGM2 F13A1	1.03e-05	3	65	2	22045386
Pubmed	Cross-linking of wild-type and mutant alpha 2-antiplasmins to fibrin by activated factor XIII and by a tissue transglutaminase.	TGM2 F13A1	1.03e-05	3	65	2	10958788
Pubmed	USP47 Promotes Tumorigenesis by Negative Regulation of p53 through Deubiquitinating Ribosomal Protein S2.	MDM2 USP47	1.03e-05	3	65	2	32370049
Pubmed	MicroRNA-101-3p Suppresses Cancer Cell Growth by Inhibiting the USP47-Induced Deubiquitination of RPL11.	MDM2 USP47	1.03e-05	3	65	2	35205710
Pubmed	Assessment of expression and specific activities of transglutaminases TG1, TG2, and FXIII-A during osteoclastogenesis.	TGM2 F13A1	1.03e-05	3	65	2	31786225
Pubmed	Arterial vimentin is a transglutaminase substrate: a link between vasomotor activity and remodeling?	TGM2 F13A1	1.03e-05	3	65	2	17476115
Pubmed	FXIIIA and TGF-beta over-expression produces normal musculo-skeletal phenotype in TG2-/- mice.	TGM2 F13A1	1.03e-05	3	65	2	18594942
Pubmed	TWIK-related acid-sensitive K+ channel 2 promotes renal fibrosis by inducing cell-cycle arrest.	KCNK5 FTO	1.03e-05	3	65	2	36465115
Pubmed	The hypothalamic RFamide, QRFP, increases feeding and locomotor activity: The role of Gpr103 and orexin receptors.	QRFPR HCRTR1	1.03e-05	3	65	2	36251705
Pubmed	Normal Bone Deposition Occurs in Mice Deficient in Factor XIII-A and Transglutaminase 2.	TGM2 F13A1	1.03e-05	3	65	2	25680676
Pubmed	Cre/lox Studies Identify Resident Macrophages as the Major Source of Circulating Coagulation Factor XIII-A.	MPL F13A1	1.03e-05	3	65	2	28596376
Pubmed	Transglutaminase 2 limits the extravasation and the resultant myocardial fibrosis associated with factor XIII-A deficiency.	TGM2 F13A1	1.03e-05	3	65	2	31874419
Pubmed	MDM2 Inhibits Axin-Induced p53 Activation Independently of its E3 Ligase Activity.	MDM2 AXIN1	2.06e-05	4	65	2	23826318
Pubmed	Variant mapping and mutation discovery in inbred mice using next-generation sequencing.	PCSK5 ADAR	2.06e-05	4	65	2	26552429
Pubmed	alpha(2)-plasmin inhibitor is a substrate for tissue transglutaminase: an in vitro study.	TGM2 F13A1	2.06e-05	4	65	2	10963790
Pubmed	Renal cell carcinoma escapes death by p53 depletion through transglutaminase 2-chaperoned autophagy.	TGM2 MDM2	2.06e-05	4	65	2	27031960
Pubmed	Cracking the egg: molecular dynamics and evolutionary aspects of the transition from the fully grown oocyte to embryo.	BPTF OSBPL9 ALS2 FAM47E DEPDC7 ELOF1	3.36e-05	326	65	6	17015433
Pubmed	Association of coagulation factor XIII-A with Golgi proteins within monocyte-macrophages: implications for subcellular trafficking and secretion.	MPL F13A1	3.43e-05	5	65	2	20086247
Pubmed	Epidermal growth factor receptor-mediated tissue transglutaminase overexpression couples acquired tumor necrosis factor-related apoptosis-inducing ligand resistance and migration through c-FLIP and MMP-9 proteins in lung cancer cells.	TGM2 TNFSF10	3.43e-05	5	65	2	21525012
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	DCP1B TRIO KIF26B CEP192 AXIN1	4.60e-05	209	65	5	36779422
Pubmed	ACAA2 is a ligand-dependent coactivator for thyroid hormone receptor β1.	FBN2 L3MBTL1 CHD5 CHD9	6.14e-05	113	65	4	34474245
Pubmed	Focal amplifications are associated with high grade and recurrences in stage Ta bladder carcinoma.	MDM2 MYBL2	7.18e-05	7	65	2	19821490
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	FBN2 TRIO NAP1L1 MAGI3 CEP192 SEPTIN7 USP47 KLHL22	1.86e-04	853	65	8	28718761
Pubmed	Coupled deglycosylation-ubiquitination cascade in regulating PD-1 degradation by MDM2.	MDM2 KLHL22	1.87e-04	11	65	2	37379210
Pubmed	Pathway analysis in HEK 293T cells overexpressing HIV-1 tat and nucleocapsid.	PCSK5 NAP1L1	2.65e-04	13	65	2	19884766
Pubmed	Isolation and characterization of cDNAs corresponding to two human calcium, calmodulin-regulated, 3',5'-cyclic nucleotide phosphodiesterases.	PDE6A PDE9A	2.65e-04	13	65	2	8557689
Pubmed	FoxN1 mediates thymic cortex-medulla differentiation through modifying a developmental pattern based on epithelial tubulogenesis.	TNFRSF11A LY75	3.56e-04	15	65	2	31552487
Pubmed	Common body mass index-associated variants confer risk of extreme obesity.	FBN2 FTO	3.56e-04	15	65	2	19553259
Pubmed	Cell-free cotranslation and selection using in vitro virus for high-throughput analysis of protein-protein interactions and complexes.	MDM2 ELOF1	4.06e-04	16	65	2	15867431
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	MIER2 BPTF NAP1L1 KCNK5 FTO MYBL2	4.99e-04	536	65	6	15840001
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	MIER2 BPTF NAP1L1 KCNK5 FTO MYBL2	5.08e-04	538	65	6	10512203
Pubmed	Single nucleotide polymorphisms in the Wnt and BMP pathways and colorectal cancer risk in a Spanish cohort.	ADAR AXIN1	5.16e-04	18	65	2	20844743
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	BPTF OSBPL9 OGDHL ALS2 MDM2	5.96e-04	363	65	5	14691545
Pubmed	Differential expansion of zinc-finger transcription factor loci in homologous human and mouse gene clusters.	ZNF283 ZNF229	6.39e-04	20	65	2	12743021
Pubmed	Dorsal root ganglion axon bifurcation tolerates increased cyclic GMP levels: the role of phosphodiesterase 2A and scavenger receptor Npr3.	PDE6A PDE9A	7.06e-04	21	65	2	27740716
Pubmed	BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates.	DCP1B MRPL24 USP47 AXIN1	8.62e-04	226	65	4	25900982
Pubmed	Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	MAGI3 ALS2 CEP192	9.11e-04	101	65	3	10997877
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	MIER2 BPTF CHD5 BAZ1B CHD9 MYBL2	9.60e-04	608	65	6	36089195
Pubmed	Overview of PDEs and their regulation.	PDE6A PDE9A	1.00e-03	25	65	2	17307970
Pubmed	Integrated genome-wide association, coexpression network, and expression single nucleotide polymorphism analysis identifies novel pathway in allergic rhinitis.	FAM20C FTO	1.00e-03	25	65	2	25085501
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PCSK5 FAM20C TRIO CHD5 KCNK5 OGDHL CEP192 MYBL2	1.03e-03	1105	65	8	35748872
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	BPTF UBA7 MDM2 MRPL24 ADAR USP47 MYBL2	1.08e-03	857	65	7	25609649
Pubmed	Mapping Extracellular Protein-Protein Interactions Using Extracellular Proximity Labeling (ePL).	TGM2 FBN2 C7 F13A1	1.20e-03	247	65	4	39238192
Pubmed	Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymes.	MTARC1 USP47	1.26e-03	28	65	2	22118674
Pubmed	Human transcription factor protein interaction networks.	BPTF FBN2 DCP1B CHD5 BAZ1B CEP192 MDM2 MRPL24 MYBL2	1.31e-03	1429	65	9	35140242
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	BPTF PDE9A TRIO AFF3 OSBPL9 MAGI3 CHD9 CEP192 MTARC1	1.74e-03	1489	65	9	28611215
Pubmed	Substrate trapping proteomics reveals targets of the βTrCP2/FBXW11 ubiquitin ligase.	MAGI3 USP47 AXIN1	1.80e-03	128	65	3	25332235
Cytoband	16q12.2	CHD9 FTO	6.28e-04	26	65	2	16q12.2
Cytoband	19q13.31	ZNF283 ZNF229	7.82e-04	29	65	2	19q13.31
Cytoband	2q33.1	STRADB ALS2	2.41e-03	51	65	2	2q33.1
GeneFamily	Transglutaminases	TGM2 F13A1	2.56e-04	9	49	2	773
GeneFamily	PHD finger proteins	BPTF CHD5 BAZ1B	1.86e-03	90	49	3	88
GeneFamily	Phosphodiesterases	PDE6A PDE9A	1.91e-03	24	49	2	681
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Interneuron\|GW09 / Sample Type, Dataset, Time_group, and Cell type.	SRRD PCSK5 TGM2 CHD5 C7 GRM3	4.75e-07	200	65	6	a6500d0d2e8bcac92381ab771dbdee66b0e1d48e
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TNFSF10 KIF26B AFF3 ALS2 NSMCE3	4.71e-06	168	65	5	c7021748003e5949f7caf7b3291c5bad294948c1
ToppCell	Megakaryocytic-erythropoietic-Erythro-cells-Erythrocyte\|Megakaryocytic-erythropoietic / Lineage, cell class and subclass	ACSL6 TGM2 STRADB MINPP1 ELOF1	9.48e-06	194	65	5	f0ababe8daa57f6827a3e2e72c884d9e8b2687a3
ToppCell	Megakaryocytic-erythropoietic-Erythro-cells\|Megakaryocytic-erythropoietic / Lineage, cell class and subclass	ACSL6 TGM2 STRADB MINPP1 ELOF1	9.96e-06	196	65	5	092caba6726d1acd409a8be335100764d0724e64
ToppCell	LPS-IL1RA-Myeloid-Monocytes,_Macrophages-Erythroid\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ACSL6 STRADB RENBP F13A1	5.85e-05	144	65	4	7c471e332f87d60f4dbed01f3e66bf39995218d0
ToppCell	Fetal_29-31_weeks-Mesenchymal-chondrocyte-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TGM2 MAOB C7 MYBL2	7.04e-05	151	65	4	32d35906f4b2bd46b173e87f2dec972eb5da87b3
ToppCell	Adult-Immune-interstitial_macrophage_(C1Q_positive)-D122\|Adult / Lineage, Cell type, age group and donor	RENBP TNFRSF11A DEPDC7 F13A1	1.02e-04	166	65	4	be284e2e596390f05305c7bcfc316f87b963fc0b
ToppCell	droplet-Lung-nan-21m-Myeloid-Interstitial_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHD5 FCRLB RENBP TNFRSF11A	1.19e-04	173	65	4	31ea04e65876c42b90245d280f0b6439bfffbace
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MAOB SYT9 TNFRSF11A F13A1	1.19e-04	173	65	4	5aa4d45a01d2d09eff8b4deb32bd91ab2471210a
ToppCell	droplet-Lung-nan-21m-Myeloid-lung_macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHD5 FCRLB RENBP TNFRSF11A	1.19e-04	173	65	4	1cff815536f620e32b9805666e1aa711462c2d25
ToppCell	droplet-Pancreas-Exocrine-24m-Epithelial-pancreatic_ductal_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGM2 KCNK5 MAGI3 FAM47E	1.24e-04	175	65	4	6bb8fc2959583644f16b22e906af91af62a3a633
ToppCell	droplet-Pancreas-Exocrine-24m-Epithelial-pancreatic_ductal_cel\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGM2 KCNK5 MAGI3 FAM47E	1.24e-04	175	65	4	8902c38067f025b094ca9c28c449c32a66eded1c
ToppCell	droplet-Pancreas-Exocrine-24m\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGM2 KCNK5 MAGI3 FAM47E	1.30e-04	177	65	4	a5b54792ef948a1e1de66301a60e051250189f59
ToppCell	356C-Fibroblasts-Fibroblast-G\|356C / Donor, Lineage, Cell class and subclass (all cells)	TGM2 MAOB C7 DEPDC7	1.30e-04	177	65	4	8220cc2fc0ee8764a67a3be51d75248be2453040
ToppCell	356C-Fibroblasts-Fibroblast-G-\|356C / Donor, Lineage, Cell class and subclass (all cells)	TGM2 MAOB C7 DEPDC7	1.30e-04	177	65	4	7617270f49cd6b7ba66db72d20560cee985012b2
ToppCell	droplet-Bladder-nan-24m-Epithelial-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE6A FAM47E C7 GRM3	1.36e-04	179	65	4	dfd9d29281510d32f1a2e8336d2e58ef496cfd1d
ToppCell	10x5'v1-week_17-19-Myeloid_macrophage-stroma-monocytoid_macrophage\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	FAM20C RENBP TNFRSF11A F13A1	1.39e-04	180	65	4	ba4c1fb55e8f1095bea6968417fefcf5f700926b
ToppCell	3'-Distal_airway-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MAOB ALS2 RENBP HCRTR1	1.39e-04	180	65	4	8bd9e12589bff64987bac30af4d2514ba6f09300
ToppCell	wk_08-11-Mesenchymal-Fibroblast-Mesenchymal_2\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	FBN2 PRICKLE1 KIF26B SEPTIN7	1.42e-04	181	65	4	9b2d207dc9fc2228a1555ed360286bb7c2d988ff
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-5\|TCGA-Colorectal / Sample_Type by Project: Shred V9	IMPACT CEP192 TNFRSF11A MDM2	1.42e-04	181	65	4	8fcc9e77fee7c248df26b6c59b10e672242e2084
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	TRIO TNFSF10 CHD9 ADAR	1.48e-04	183	65	4	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	MS-IIF-Others-RBC\|IIF / Disease, condition lineage and cell class	SRRD TGM2 STRADB GRM3	1.51e-04	184	65	4	578bde79b464ed12dd9a53dd8e2839e156220a60
ToppCell	Substantia_nigra-Neuronal-Inhibitory\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	KIF26B CHD5 IMPACT HCRTR1	1.57e-04	186	65	4	9d3efe2a4feea2bc205a7e45b9b9f9ed9b3609ce
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PCSK5 QRFPR FBN2 KIF26B	1.60e-04	187	65	4	85f1678338a47d91e296f0620d4887f057eb7e70
ToppCell	T_cells-ISG-high_CD4+_T_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	UBA7 PDE9A TNFSF10 ADAR	1.64e-04	188	65	4	6f8946d4710f6e32c937213f99b790b098b8819c
ToppCell	10x5'-GI_large-bowel-Myeloid_Monocytic\|GI_large-bowel / Manually curated celltypes from each tissue	FAM20C FBN2 TNFRSF11A F13A1	1.64e-04	188	65	4	d0045fdda757d191dabc7853f6a6e99c0e97d93d
ToppCell	10x5'-GI_large-bowel-Myeloid_Monocytic-Classical_monocytes\|GI_large-bowel / Manually curated celltypes from each tissue	FAM20C FBN2 TNFRSF11A F13A1	1.64e-04	188	65	4	0bcf04aa47738f43c1a87dae5dc487738ee86f8c
ToppCell	Influenza_Severe-RBC\|World / Disease group and Cell class	ACSL6 TGM2 STRADB MINPP1	1.64e-04	188	65	4	f0438e6a77ee1f0456cb65926685266fff470983
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	KIF26B CHD5 IMPACT HCRTR1	1.64e-04	188	65	4	b73e8a40393c3f656e2fcfe395a761b1f985c254
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRIO PRICKLE1 TNFSF10 KIF26B	1.67e-04	189	65	4	3b48b0d220cc24d5170713d61fa91f5bb6c21841
ToppCell	3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-Mast_cell\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MAOB TNFSF10 ALS2 RENBP	1.67e-04	189	65	4	7bc6e152fb4fe5cd6db9407929c15843a5d8f8c4
ToppCell	Megakaryocytic-erythropoietic-Erythro-cells-Erythrocyte\|World / Lineage, cell class and subclass	ACSL6 TGM2 STRADB MINPP1	1.67e-04	189	65	4	826457adac7477102f86aceb97a8b77929b3e6f9
ToppCell	COVID-19-kidney-PCT-S2\|kidney / Disease (COVID-19 only), tissue and cell type	PCSK5 QRFPR TNFSF10 KCNK5	1.67e-04	189	65	4	0be5c669b6b308bd98ddb70c84877c62a6244bbd
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TGM2 PRICKLE1 AFF3 C7	1.67e-04	189	65	4	c734e5693808a0333139e87bd5be2597a9252afe
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PRICKLE1 KIF26B AFF3 C7	1.71e-04	190	65	4	2306aa9dbeaef3be8484a5b236605de23cd75d4c
ToppCell	Megakaryocytic-erythropoietic-Erythro-cells\|World / Lineage, cell class and subclass	ACSL6 TGM2 STRADB MINPP1	1.71e-04	190	65	4	6c7e016a9b425ee9418acd4fe96b9779fe7bd39a
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TGM2 PRICKLE1 AFF3 C7	1.71e-04	190	65	4	2e592323085ba9c019d678ac2a784462ab470ed9
ToppCell	facs-Marrow-KLS-18m-Hematologic-MPP_Fraction_A_+_HSC\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPL TGM2 UBA7 TNFSF10	1.71e-04	190	65	4	96a9756cad5468a12591021e6d661ed269b5b3d9
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PRICKLE1 KIF26B AFF3 C7	1.71e-04	190	65	4	1f83f7f24288a3b9ab33c2e113e845dba96adc8a
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	TGM2 MAOB NAP1L1 C7	1.71e-04	190	65	4	71e112dfb8c3190fe0286b45a046ea789eb6a8db
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TGM2 PRICKLE1 AFF3 C7	1.71e-04	190	65	4	445952b70abffadb6ccc1ed4bbf61a88b06b73b3
ToppCell	severe_COVID-19-RBC\|severe_COVID-19 / disease group, cell group and cell class (v2)	ACSL6 TGM2 STRADB MINPP1	1.71e-04	190	65	4	3a5723c2daf58c1932edd70910db4b8b30f63f42
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PRICKLE1 KIF26B AFF3 C7	1.74e-04	191	65	4	a58c75e9580139fb370b498d95660f10f3a2a27b
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TGM2 PRICKLE1 AFF3 C7	1.74e-04	191	65	4	c54c420a94dc749ebc67fc64c5614663f4b9798d
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TGM2 PRICKLE1 AFF3 C7	1.74e-04	191	65	4	806b94f567ea09a9f443cd4091e70cdb1253ac08
ToppCell	ILEUM-non-inflamed-(6)_ILC3\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	TGM2 PRICKLE1 AFF3 NAP1L1	1.74e-04	191	65	4	6eaf72b41084404bee0db04e4605db745a74995f
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TGM2 PRICKLE1 AFF3 C7	1.74e-04	191	65	4	cb0aee740b08f7d5fdd2717ecf7429043b277ae7
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRIO PRICKLE1 TNFSF10 KIF26B	1.74e-04	191	65	4	1cb02007adb344f17ef73d58890f91298c7cf5a1
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PRICKLE1 KIF26B AFF3 C7	1.74e-04	191	65	4	107113b930d9ad171f1b2aa20df4567c94fae7d8
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PRICKLE1 KIF26B AFF3 C7	1.74e-04	191	65	4	bc353a79a1d11ca52bba5e3874a80d432e1a7715
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PRICKLE1 KIF26B AFF3 C7	1.78e-04	192	65	4	9093a9e94a25682d109a7f6edc256a25a61103a0
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PRICKLE1 KIF26B AFF3 C7	1.78e-04	192	65	4	9ed5d49621ec1aa01716dc369bba1450b5f015f5
ToppCell	10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-mast_cell\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	MAOB TNFSF10 ALS2 RENBP	1.78e-04	192	65	4	9ad9dce4fcbb133b135079eb4cc32c7ead7f0243
ToppCell	COPD-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	TGM2 MAOB KIF26B NAP1L1	1.78e-04	192	65	4	62904f94dfce430456f05066522cbf9bd29f4d7e
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	TRIO AFF3 CHD9 MYBL2	1.81e-04	193	65	4	08696a99309f5b088692ddac8cca35413b5e810d
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D231\|Adult / Lineage, Cell type, age group and donor	TGM2 MAOB KIF26B C7	1.81e-04	193	65	4	ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a
ToppCell	Megakaryocytic-erythropoietic\|World / Lineage, cell class and subclass	TGM2 STRADB MINPP1 F13A1	1.81e-04	193	65	4	805c2e2e5d8a9df5ce796d5c0206d6493ab53c88
ToppCell	Control-NK_CD56bright\|Control / Disease condition and Cell class	KIF26B AFF3 CHD9 TNFRSF11A	1.81e-04	193	65	4	8b1e7a226a6057e1097c1525984127b54e823876
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PCSK5 FBN2 KIF26B SYT9	1.85e-04	194	65	4	83863da11dfbe59b2d0a2c08db40b537c150588c
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PRICKLE1 KIF26B AFF3 C7	1.85e-04	194	65	4	240d122dcb9dd1ab2867503ad85869853adcacae
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TGM2 MAOB KIF26B C7	1.85e-04	194	65	4	35f132cc38ac133be01834ed0946188aa0757eb4
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PRICKLE1 KIF26B AFF3 C7	1.85e-04	194	65	4	ae7df037592f1c20c9d32be15fe6fc3c562ebeb1
ToppCell	LA-02._Fibroblast_II\|LA / Chamber and Cluster_Paper	PCSK5 OSBPL9 CHD9 C7	1.85e-04	194	65	4	234d1494c114cce77c619708bbcd8d5ce805f19b
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PRICKLE1 KIF26B AFF3 C7	1.88e-04	195	65	4	d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d
ToppCell	LA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	PCSK5 OSBPL9 CHD9 C7	1.88e-04	195	65	4	a78b605b49acd8c9d68716266ca269dafcd910b9
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	TGM2 MAOB KIF26B C7	1.88e-04	195	65	4	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	343B-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	SYT9 TNFRSF11A F13A1 MYBL2	1.88e-04	195	65	4	67b05a0cd2ca9924eca81a92cc6330eecb9d963c
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PRICKLE1 KIF26B AFF3 C7	1.88e-04	195	65	4	44d7bef5f59c2c2bad1392ee6aabdaa5d7f531d9
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PRICKLE1 KIF26B AFF3 C7	1.92e-04	196	65	4	a12dd986df65c36f248cf10815c3b8b6238613b0
ToppCell	15-Trachea-RBC-RBC\|Trachea / Age, Tissue, Lineage and Cell class	ACSL6 STRADB MINPP1 MYBL2	1.92e-04	196	65	4	511bfc06c34d5add2ae561cca463d1e4e2d43e20
ToppCell	367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	TGM2 MAOB NAP1L1 C7	1.92e-04	196	65	4	6730743cf088c419ccc2d28765769fc09d3ba6a7
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	QRFPR FBN2 C7 NSMCE3	1.92e-04	196	65	4	308fa54385ca34e9e590967d4553b84aad96c92f
ToppCell	367C-Fibroblasts-Fibroblast-C_(Myofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	TGM2 MAOB NAP1L1 C7	1.92e-04	196	65	4	21dab89f3699037138a9c7a0e4dc98739a9fad9c
ToppCell	10x5'v1-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-mast_cell\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	MAOB TNFSF10 ALS2 RENBP	1.92e-04	196	65	4	e08f90f7a923c2846cac859519b8dc7c0ac7cd03
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PRICKLE1 KIF26B AFF3 C7	1.92e-04	196	65	4	ba869f7a86f37fd6d84d6ad69baca0e0faaf5887
ToppCell	10x5'-bone_marrow-Hematopoietic_Erythro-Mega\|bone_marrow / Manually curated celltypes from each tissue	TGM2 STRADB MINPP1 MYBL2	1.92e-04	196	65	4	707eecbb2b14051fd843afa66035014ec59e6bd5
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PRICKLE1 KIF26B AFF3 C7	1.92e-04	196	65	4	30ad56d49000e4ddce73b4443b3994564bd1e2d6
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PRICKLE1 KIF26B AFF3 C7	1.92e-04	196	65	4	3e6803587d8566fd08cb8b290be3b6461743d79c
ToppCell	10x5'-bone_marrow-Hematopoietic_Erythro-Mega-Erythrocytic_early\|bone_marrow / Manually curated celltypes from each tissue	TGM2 STRADB MINPP1 MYBL2	1.92e-04	196	65	4	507254c4c00e535fe01851431b5b74a5f15d9592
ToppCell	15-Trachea-RBC\|Trachea / Age, Tissue, Lineage and Cell class	ACSL6 STRADB MINPP1 MYBL2	1.92e-04	196	65	4	bf2670e5ae996a19987bc70aa5a37d133db789eb
ToppCell	10x3'2.3-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast-mast_cell\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	MAOB TNFSF10 ALS2 RENBP	1.92e-04	196	65	4	03710e2a843279124a45a271bffb132835e6081c
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PRICKLE1 KIF26B AFF3 C7	1.96e-04	197	65	4	6d027119a5f7ca2aac1b10837e43f9a2bb54db85
ToppCell	10x3'2.3-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	MAOB TNFSF10 ALS2 RENBP	1.96e-04	197	65	4	5e4a004052b8560223673a339d4a0d729e533def
ToppCell	10x5'v1-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-mast_cell\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	MAOB TNFSF10 ALS2 RENBP	1.96e-04	197	65	4	61f909737c5f630beffdd326c6844215643dbdde
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PRICKLE1 KIF26B AFF3 C7	1.96e-04	197	65	4	b349f8e96d61a4c296af64711e11fc44459a9413
ToppCell	tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs\|Fibroblasts / Location, Cell class and cell subclass	TGM2 MAOB NAP1L1 C7	1.96e-04	197	65	4	44f37a98f07c3e46a7e8fd3b64c2b2b44d5bbe40
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PRICKLE1 KIF26B AFF3 C7	1.96e-04	197	65	4	c2e390653d5dee7e731c1840cfdab41987dede9b
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	MAOB PRICKLE1 KIF26B C7	1.96e-04	197	65	4	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	TRIO AFF3 MAGI3 FTO	2.00e-04	198	65	4	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	10x5'v1-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	MAOB TNFSF10 ALS2 RENBP	2.00e-04	198	65	4	a1247a5efd92f95c6227c0e71dc8a0427eb54b7f
ToppCell	Control-Control-Others-HSPC\|Control / Disease, condition lineage and cell class	MPL FBXW9 KCNK5 MINPP1	2.04e-04	199	65	4	b71169be0d916b2ed139a3122d78bb154c71edb4
ToppCell	Sepsis-Bac-SEP-Lymphocyte-T/NK-dn_T\|Bac-SEP / Disease, condition lineage and cell class	ACSL6 FCRLB FTO USP47	2.04e-04	199	65	4	4150a479b80596accf679b37aa9b0ac15cc132b2
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	TRIO AFF3 MAGI3 FTO	2.04e-04	199	65	4	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Influenza-Influenza_Severe-Others-RBC\|Influenza_Severe / Disease, condition lineage and cell class	ACSL6 TGM2 STRADB MINPP1	2.04e-04	199	65	4	da0fec0a492bc3827d9066d2590bcd466cd45564
ToppCell	343B-Fibroblasts-Fibroblast-G\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	TGM2 MAOB NAP1L1 C7	2.04e-04	199	65	4	212e89d097753790061310373a1fafba773488b6
ToppCell	(7)_Mast_cell\|World / shred on Cell_type and subtype	MAOB TNFSF10 ALS2 RENBP	2.04e-04	199	65	4	c0b5f1cb435da99a7e2ebac9ee7d7b1bd0e49b42
ToppCell	343B-Fibroblasts-Fibroblast-G-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	TGM2 MAOB NAP1L1 C7	2.04e-04	199	65	4	14b676aa289c0578a37be32cec3ea285c79d97cc
ToppCell	Caecum-(7)_Mast_cell\|Caecum / shred on region, Cell_type, and subtype	MAOB TNFSF10 ALS2 RENBP	2.08e-04	200	65	4	d23fe8644ce42ace51fcde43cb4cd22a99300c02
ToppCell	Transverse-(7)_Mast_cell-(70)_Mast\|Transverse / shred on region, Cell_type, and subtype	MAOB TNFSF10 ALS2 RENBP	2.08e-04	200	65	4	aa17354c83b0967707d995e4b74e042ac211f814
ToppCell	Sigmoid-(6)_Macrophage-(61)_LYVE1_Macrophage\|Sigmoid / shred on region, Cell_type, and subtype	FAM20C FBN2 TNFRSF11A F13A1	2.08e-04	200	65	4	bc0280d52e4edc2c5edf4ead164a1c7cf3fccd60
Drug	3,5-dinitrosalicylic acid hydrazide	FBN2 ADAR	8.03e-06	2	65	2	CID003663247
Drug	Maprotiline hydrochloride [10347-81-6]; Up 200; 12.8uM; MCF7; HT_HG-U133A	TGM2 L3MBTL1 TNFSF10 KCNK5 F13A1 ANAPC13	1.82e-05	192	65	6	3236_UP
Drug	Chlorambucil [305-03-3]; Up 200; 13.2uM; MCF7; HT_HG-U133A	MPL MIER2 TGM2 KIF26B GRM3 F13A1	2.16e-05	198	65	6	4345_UP
Drug	Cyclacillin [3485-14-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A	MPL PCSK5 FBN2 CHD5 MDM2 F13A1	2.16e-05	198	65	6	4358_UP
Drug	Ioversol [87771-40-2]; Down 200; 5uM; PC3; HT_HG-U133A	L3MBTL1 TRIO TNFSF10 SEPTIN7 MDM2 KLHL22	2.16e-05	198	65	6	6726_DN
Disease	pulmonary embolism (is_implicated_in)	FTO F13A1	4.61e-05	5	64	2	DOID:9477 (is_implicated_in)
Disease	Mood Disorders	MAOB FTO GRM3 HCRTR1	4.94e-04	168	64	4	C0525045
Disease	protein C measurement	KCNK5 BAZ1B	6.17e-04	17	64	2	EFO_0004633
Disease	autoimmune thyroid disease, type 1 diabetes mellitus	QRFPR MAGI3	6.93e-04	18	64	2	EFO_0006812, MONDO_0005147
Disease	unipolar depression, bipolar disorder, schizophrenia	PCSK5 FTO	8.58e-04	20	64	2	EFO_0003761, MONDO_0004985, MONDO_0005090
Disease	survival time, coronary artery disease	PDE9A KLHL22	1.94e-03	30	64	2	EFO_0000714, EFO_0001645
Disease	arteriosclerosis (is_implicated_in)	TNFSF10 F13A1	2.07e-03	31	64	2	DOID:2349 (is_implicated_in)

Protein segments in the cluster

Peptide	Gene	Start	Entry
EWDLESLCVYEPDRN	AFF3	11	P51826
DLPYDQCTWEIDDID	CHD5	616	Q8TDI0
AVPADEKWKAVFDEC	ALS2	1286	Q96Q42
EVAELLKEEFPAWYE	BAZ1B	71	Q9UIG0
GCYDLPEDYIRWEDA	GRM3	561	Q14832
QEDEWLSAAIDCLEY	DEPDC7	261	Q96QD5
AELIDCLDKDYWEAE	BPTF	501	Q12830
ELYDLEETPVSWKDD	CBWD5	336	Q5RIA9
EPVDVYSDWIDACEA	ELOF1	66	P60002
DFLYEKEHICCLEEW	QRFPR	191	Q96P65
INAIYEPTEEECEWK	NAP1L1	121	P55209
EDGECWVYDEPLLKR	OSBPL9	716	Q96SU4
EALEPVHYEEKNWCE	MAOB	376	P27338
DEELAGKYAELGDWC	RENBP	206	P51606
EEKNFDWPAACIALE	FBXW9	136	Q5XUX1
FPLWYEEALKDEEER	MAGEA10	326	P43363
CEDGELPYGWEKIED	MAGI3	336	Q5TCQ9
CDVYAEDSWDELLIG	MTARC1	246	Q5VT66
ADQKPECRPYWEKDD	FTO	466	Q9C0B1
WELDSLEYLEALECV	KIF26B	2066	Q2KJY2
ELYDLEETPVSWKDD	CBWD2	336	Q8IUF1
ELYDLEETPVSWKDD	CBWD1	336	Q9BRT8
ANEKCSPSEYWDEDA	PCSK5	1451	Q92824
DRISEECEPWDAQDY	KCNK5	396	O95279
DPDNFCWEKYLEETG	L3MBTL1	486	Q9Y468
AEKYPGAELAWCQEE	OGDHL	931	Q9ULD0
TREVYGKEPWECEEE	PDE6A	471	P16499
EVAEPWVDCLLEEYF	PDE9A	471	O76083
YGWIVADDCDETEDK	LY75	51	O60449
NPWCEDDAVYLDNEK	F13A1	186	P00488
AIYGEEWCVIDDCAK	IMPACT	21	Q9P2X3
WYEDSLECLSDLKPE	PRICKLE1	516	Q96MT3
VCDERWADDLYPKIY	HCRTR1	201	O43613
GIWFYDKEECQRIAE	DCP1B	111	Q8IZD4
DDAWREDKLPYEDVA	ANAPC13	16	Q9BS18
CSLPYEDSTWELKED	CHD9	801	Q3L8U1
YDVEKDCWEEGPQLD	KLHL22	566	Q53GT1
VNWCLADGYDLEILD	ADAR	1126	P55265
KAEWEVDPDYCEEVK	FAM20C	416	Q8IXL6
GYLPTLNEDEEWKCD	AXIN1	236	O15169
LKWALEEYLDEFDPC	C7	441	P10643
ELYDLEETPVSWKDD	CBWD3	336	Q5JTY5
DYAQFWDVECHPLKE	CEP192	2361	Q8TEP8
EPEVEELESYWCEAA	FCRLB	256	Q6BAA4
EQCYLKWDEDECIHP	FBN2	1001	P35556
EEYGEFCKNLTNDWE	HSP90AA2P	306	Q14568
CEKIYENEDQLLWDP	MIER2	216	Q8N344
ADFPRECILWKDIEY	SYT9	331	Q86SS6
PDRKLEDTWAYCQDT	FAM47E	151	Q6ZV65
ESDPDAWCDLSKFDL	MYBL2	316	P10244
FEEDPEISLADYWKC	MDM2	291	Q00987
VEPISDEDWYLFCGD	MRPL24	46	Q96A35
LVDVEELNYWACKGE	ACSL6	491	Q9UKU0
ARDEYWKCLDENLED	COA6	61	Q5JTJ3
AWCPADAVYLDSEEE	TGM2	141	P21980
WCDVFDIDDAKVLEY	MINPP1	301	Q9UNW1
WLYFDALDCLPEDGE	UBA7	386	P41226
CWQPVIDYIDSKFED	SEPTIN7	126	Q16181
LYKWEFEESEEDPVT	USP47	216	Q96K76
WEFREEPDYQDCEDL	SRRD	311	Q9UH36
DRYPIWENCEEEEKT	MPL	326	P40238
KDWPAQYCEALADEE	NSMCE3	276	Q96MG7
LDTEDTVYKCNWDDD	ZNF229	206	Q9UJW7
WTEPECDFPDEKDSY	STRADB	401	Q9C0K7
CFLKEDDSYWDPNDE	TNFSF10	56	P50591
EQEYKREEDWCGGAD	TRIO	1031	O75962
CGPDEYLDSWNEEDK	TNFRSF11A	71	Q9Y6Q6
EWECLDPAQRDLYVD	ZNF283	86	Q8N7M2
CEIEELSPKWFIDED	ZNF527	91	Q8NB42